Acute Myelogenous Leukemia and its Microenvironment: A Molecular Conversation

Area of Science:

• Hematology
• Cancer Biology
• Molecular Oncology

Background:

• Acute myelogenous leukemia (AML) relapse is a major challenge, even after achieving complete remission.
• Eliminating minimal residual disease (MRD) remains difficult despite advances in understanding AML biology and chemoresistance.

Purpose of the Study:

• To review recent advances in understanding the interaction between leukemia cells and their microenvironment.
• To explore how this interaction contributes to AML homeostasis and MRD persistence.
• To outline therapeutic strategies targeting these interactions for MRD elimination.

Main Methods:

• Review of current scientific literature on AML microenvironment and MRD.
• Analysis of preclinical and clinical studies investigating therapeutic interventions.
• Synthesis of findings on leukemia cell-microenvironment interactions.

Main Results:

• Leukemia cells actively modify their microenvironment, creating a niche that supports their survival and proliferation.
• This reciprocal interaction, or "molecular conversation," reinforces AML homeostasis and contributes to MRD.
• Targeting these microenvironmental interactions shows promise in preclinical and clinical settings.

Conclusions:

• The leukemic microenvironment plays a critical role in AML pathogenesis and resistance to therapy.
• Disrupting the "molecular conversation" between leukemia cells and their microenvironment is a promising strategy for eradicating MRD.
• Future research should focus on developing novel therapies that target these interactions to improve long-term survival for AML patients.